Delivery Order SPE2DB22D3004-SPE2DB24FPL44
Award Date 2/26/24
Potential Completion Date 2/27/24
Potential Value $1.9K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a $7,721.20 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide RABAVERT rabies vaccine with diluents. The delivery order has a completion date of March 6, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to...
- The Defense Logistics Agency (DLA) awarded a $1,544.24 firm fixed price delivery order to Amerisourcebergen Drug Corp, a for-profit subsidiary of Amerisourcebergen Corporation, to provide RABAVERT RABIES VACCINE WITH DILUENTS. The delivery order has a completion date of February 2, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver...
- The U.S. Defense Logistics Agency (DLA) awarded a $11,581.80 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of RABAVERT rabies vaccine with diluents. The delivery order has an ultimate completion date of April 15, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract with DLA valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary contract vehicle for...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of RABAVERT rabies vaccine with diluents. The contract has a potential value of $3,860.60 and a completion date of February 2, 2024. Amerisourcebergen Drug Corp is a prime contractor providing pharmaceutical products and medical supplies to U.S. government agencies, including the Department of Defense. This delivery...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide RABAVERT rabies vaccine with diluents. The $38,606.00 delivery order has a completion date of February 27, 2024. Amerisourcebergen Drug Corp, a for-profit organization, is the prime contractor on an indefinite delivery contract (IDC) valued up to $999,999,999.00 with DLA to deliver pharmaceutical products and medical...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $2,895.45 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide RABAVERT rabies vaccine with diluents. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, valued at up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen to deliver...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of RABAVERT rabies vaccine with diluents. The $1,930.30 delivery order has a completion date of March 6, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025, which serves as the...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order worth $1,497.82 to Amerisourcebergen Drug Corp, a wholly-owned subsidiary of Amerisourcebergen Corporation, for the supply of RABAVERT rabies vaccine with diluents. This delivery order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded to Amerisourcebergen Drug Corp by DLA, which serves as the primary contract vehicle for the company to deliver pharmaceutical...
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide RABAVERT RABIES VACC W-DILUENTS. The contract has a potential value of $1,930.30 and a completion date of February 12, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside was used for this award. Amerisourcebergen Drug Corp also holds an indefinite delivery contract (IDC) with DLA, valued at up to...
- The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract valued at $8,945.46 to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of RABAVERT RABIES VACC W-DILUENTS and has an ultimate completion date of May 10, 2024. This order is placed under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, worth up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB24FPL44Delivery Order
The Defense Logistics Agency awarded a $1,930.30 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of RABAVERT rabies vaccine with diluents. The delivery order has a completion date of February 27, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA with a potential value of $999,999,999.00 and a performance period through December 31, 2025, which serves as the primary contract vehicle for delivering pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. No set-aside designation was used for this specific delivery order.
Generated 6/2/24, 12:25 AM